Cuprina (CUPR) said Friday it closed its initial public offering of 3 million class A ordinary shares at $4 a piece for gross proceeds of $12 million.
The biomedical and biotechnology company said it plans to use the net proceeds for expansion into new markets, research and development, building brand awareness, investing in equipment and infrastructure, and working capital and general corporate purposes.
Price: 4.11, Change: -0.04, Percent Change: -0.96
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.